Isolated Absent Thelarche in a Patient With Neurofibromatosis Type 1 and Acromegaly.

CONCLUSIONS: Neither neurofibromatosis type 1, acromegaly, nor neurofibromatosis 1 microdeletion syndrome are linked to absent thelarche. After attempting hormone therapy, patients with absent thelarche should be evaluated for congenital breast anomalies, estrogen receptor abnormalities, or gene defects. Psychological and surgical consultation should also be offered. PMID: 29215515 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29215515?dopt=Abstract

Source: Obstetrics and Gynecology - December 4, 2017 Category: OBGYN Authors: Martini AE, Zolton JR, DeCherney AH Tags: Obstet Gynecol Source Type: research